Coronavirus treatment: Gilead says positive data on remdesivir coming - Business Insider

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 11 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 51%

Philippines News News

Philippines Philippines Latest News,Philippines Philippines Headlines

Gilead's coronavirus treatment remdesivir just succeeded in a crucial study, raising hopes for a first COVID-19 drug

Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.

The antiviral drug remdesivir is being tested in several ongoing trials of COVID-19 patients. Gilead stated that one of these studies, run by the US National Institutes of Health, shows the drug works.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 729. in PH

Philippines Philippines Latest News, Philippines Philippines Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Coronavirus research: flaws in trials for remdesivir, chloroquine - Business Insider'We have no reliable data' on potential coronavirus treatments, one researcher said. Here's how that could change over the next few weeks.
Source: BusinessInsider - 🏆 729. / 51 Read more »

Coronavirus: EU rewrote coronavirus report after pressure by China - Business InsiderReferences to a Chinese campaign of 'global disinformation' about the coronavirus were removed before publication. China wins again! Shame on EU !
Source: BusinessInsider - 🏆 729. / 51 Read more »

Coronavirus antibody treatments: Eli Lilly, Regeneron, GSK, Amgen - Business Insider4 top drugmakers are studying the body's own efforts to fight off viruses as they race to find a COVID-19 treatment that could be ready by the fall Yaaaaay Yeah seriously, I can't stop itching all over!!!!
Source: BusinessInsider - 🏆 729. / 51 Read more »